In the quiet municipality of Coaña, nestled along Asturias’ rugged coastline in northern Spain, a grassroots health initiative is turning attention toward one of the world’s most silent epidemics: chronic kidney disease (CKD). La Escuela de Salud de Coaña, a community-driven wellness program supported by local health authorities, announced it will host a public educational session focused on CKD prevention, early detection, and management. The event, open to residents and healthcare advocates alike, aims to demystify a condition that affects an estimated 850 million people globally — yet remains underdiagnosed in up to 90% of early-stage cases.
Chronic kidney disease, characterized by the gradual loss of kidney function over months or years, often progresses without noticeable symptoms until significant damage has occurred. According to the World Health Organization, CKD is now the 12th leading cause of death worldwide, contributing to approximately 1.2 million annual deaths. In Spain, where aging populations and rising rates of diabetes and hypertension converge, national health surveys suggest that nearly 15% of adults over 65 show signs of reduced kidney function — many unaware of their risk.
“The kidneys are remarkable organs, but they don’t complain until they’re pushed to the brink,” said Dr. Elena Márquez, a nephrologist at Hospital Universitario Central de Asturias in Oviedo, who has collaborated with regional health outreach programs. “By the time someone feels fatigue, notices swelling, or sees changes in urination, they may already have lost 60% or more of their kidney function. That’s why initiatives like La Escuela de Salud de Coaña are vital — they bring knowledge directly to communities before crisis strikes.”
The upcoming session will cover modifiable risk factors such as uncontrolled hypertension, hyperglycemia, obesity, and excessive apply of over-the-counter painkillers like ibuprofen and naproxen. Attendees will too learn about the importance of routine screening through simple blood and urine tests — specifically serum creatinine to estimate glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) — which can detect kidney damage years before symptoms emerge.
Local organizers emphasize that the talk will be accessible to all, avoiding medical jargon in favor of practical guidance. “We want people to leave understanding not just what CKD is, but what they can do today,” said María López, coordinator of La Escuela de Salud de Coaña. “That means eating a balanced diet low in sodium and processed foods, staying hydrated without overdoing it, exercising regularly, and — most importantly — talking to their doctor about kidney health, especially if they have diabetes, high blood pressure, or a family history of kidney disease.”
Spain’s National Health System (SNS) includes kidney function testing in its preventive care portfolio for high-risk individuals, yet participation remains inconsistent, particularly in rural areas like Coaña. A 2022 study published in Nefrología, the official journal of the Spanish Society of Nephrology, found that while 78% of Spaniards over 65 had visited a primary care physician in the past year, fewer than 40% had undergone recommended CKD screening — highlighting a persistent gap between access and action.
La Escuela de Salud de Coaña operates under the broader Asturias Public Health Strategy, which prioritizes community engagement in combating non-communicable diseases. Similar initiatives have emerged across northern Spain, from Galicia to Cantabria, reflecting a regional shift toward decentralized, preventive health education. These programs often partner with local pharmacies, schools, and civic centers to reach populations that might otherwise fall through the cracks of centralized healthcare systems.
Experts stress that while advanced CKD may require dialysis or transplantation, early intervention can dramatically slow progression. Lifestyle modifications, combined with medications like ACE inhibitors or SGLT2 inhibitors — now proven to protect kidney function even in non-diabetic patients — can delay dialysis by years or even prevent it altogether. The 2023 KDIGO (Kidney Disease: Improving Global Outcomes) Clinical Practice Guidelines reinforce this, recommending early use of SGLT2 inhibitors in patients with CKD and albuminuria, regardless of diabetes status.
For residents of Coaña and surrounding villages, the session represents more than an information exchange — it’s an invitation to reclaim agency over long-term health. As life expectancy rises and chronic conditions turn into more prevalent, community-based health literacy efforts like this one may prove as vital as any hospital or clinic in shaping healthier futures.
The event is scheduled for Saturday, June 15, 2024, at 10:00 a.m. Local time in the Coaña Cultural Center, located at Calle del Sol, 33690 Coaña, Asturias. Admission is free, and informational pamphlets in both Spanish and Asturian will be available. Those unable to attend can access similar resources through the Spanish Kidney Foundation (Fundación Riñón) and the Asturias Health Service (Servicio de Salud del Principado de Asturias), which offer online tools for risk assessment and preventive care guidance.
As the global burden of kidney disease continues to grow — projected to become the 5th leading cause of years of life lost by 2040 if trends persist — local actions like those in Coaña offer a powerful counter-narrative: that prevention, education, and community solidarity can still turn the tide.
We encourage readers to share their experiences with kidney health awareness in their communities and to spread the word about upcoming sessions like this one. Your voice helps build a healthier, more informed world.